Celltrion Healthcare Co., Ltd.
091990
Rankning i aktier
#2142
Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on... Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.
Aktiekurs
$57.75
Senast synkroniserad: 2024-01-11
Marknadsvärde
$9.42B
Förändring (1 dag)
-0.25%
Förändring (1 år)
0.00%
Land
KR
Handel Celltrion Healthcare Co., Ltd. (091990)
Kategori
Healthcare
P/B-tal för Celltrion Healthcare Co., Ltd. (091990)
P/B-tal per October 2026 TTM: 5.94
Enligt Celltrion Healthcare Co., Ltd. senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 5.94. I slutet av 2021 hade företaget ett P/B-tal på 6.21.
Historik för P/B-tal för Celltrion Healthcare Co., Ltd. från 2014 till 2026
P/B-tal vid årets slut
| År | P/B-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 5.94 | 32.24% |
| 2022 | 4.49 | -27.70% |
| 2021 | 6.21 | -15.82% |
| 2020 | 7.38 | -12.83% |
| 2019 | 8.46 | -1.92% |
| 2018 | 8.63 | 5.42% |
| 2017 | 8.19 | -50.80% |
| 2016 | 16.64 | 27.60% |
| 2015 | 13.04 | 10,587.95% |
| 2014 | 0.12 | 0.00% |
P/B-tal för liknande företag eller konkurrenter
| Företag | P/B-tal | Skillnad i P/B-tal | Land |
|---|---|---|---|
| 6.251 | 5.28% |
US
|
|
| 13.2547 | 123.23% |
US
|
|
| 4.4521 | -25.02% |
AU
|
|
| 6.3632 | 7.17% |
NL
|
|
| - | - |
CH
|
